Atorvastatin calcium and Sialoadenitis - a phase IV clinical study of FDA data

Summary:

Sialoadenitis is reported as a side effect among people who take Atorvastatin calcium (atorvastatin calcium), especially for people who are female, 40-49 old, also take Aspirin, and have Adverse event.

The phase IV clinical study analyzes which people have Sialoadenitis when taking Atorvastatin calcium. It is created by eHealthMe based on reports of 72,753 people who have side effects when taking Atorvastatin calcium from the FDA, and is updated regularly.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,309 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.

What is Sialoadenitis?

Sialoadenitis (inflammation of a salivary gland) is found to be associated with 343 drugs and 326 conditions by eHealthMe. Check the latest studies of Sialoadenitis.

On Jul, 11, 2026

72,753 people reported to have side effects when taking Atorvastatin calcium.
Among them, 11 people (0.02%) have Sialoadenitis.

Could Atorvastatin calcium cause Sialoadenitis?

Among these 11 people:

What is the gender of people who have Sialoadenitis when taking Atorvastatin calcium? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Sialoadenitis when taking Atorvastatin calcium? *

What are other drugs people take besides Atorvastatin calcium? *

Aspirin: 6 people, 54.55%
Acetaminophen: 5 people, 45.45%
Citalopram Hydrobromide: 5 people, 45.45%
Hydrocortisone: 5 people, 45.45%
Mycophenolate Mofetil: 5 people, 45.45%
Oxycodone: 5 people, 45.45%
Prednisone: 5 people, 45.45%
Fentanyl: 5 people, 45.45%
Dexilant: 5 people, 45.45%
Lidocaine: 5 people, 45.45%

What are other side effects people have besides Sialoadenitis? *

Weight Decreased: 6 people, 54.55%
Blood Pressure Fluctuation: 5 people, 45.45%
Blood Pressure Systolic Increased: 5 people, 45.45%
Osteomyelitis (infection of bone): 5 people, 45.45%
Skin Disorder (skin disease): 3 people, 27.27%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 3 people, 27.27%
Tooth Disorder (tooth disease): 3 people, 27.27%
Immunodeficiency Disorders: 3 people, 27.27%
Joint Pain: 3 people, 27.27%
Wound: 2 people, 18.18%

What are the existing conditions these people have? *

Adverse Event: 5 people, 45.45%
Sleep Disorder: 1 person, 9.09%
Peripheral Vascular Disorder: 1 person, 9.09%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 9.09%
Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%
Immunodeficiency Common Variable: 1 person, 9.09%
Gastrointestinal Motility Disorder (abnormal intestinal contractions): 1 person, 9.09%
Gastric Disorder (disease of stomach): 1 person, 9.09%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 9.09%
Cardiac Disorder: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Atorvastatin calcium and have Sialoadenitis?

- Check whether Sialoadenitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atorvastatin calcium:

Atorvastatin calcium (77,309 reports)

Sialoadenitis treatments and more:

Sialoadenitis (1,917 reports)

Browse all side effects of Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sialoadenitis:

Sialoadenitis (343 drugs)

Browse all the conditions that are associated with Sialoadenitis:

Sialoadenitis (326 conditions)

Related publications that referenced our studies

Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium (the active ingredients of Atorvastatin calcium) and Atorvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.